Improved angiogenesis in response to localized delivery of macrophage-recruiting molecules

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Hsu, Chih Wei ^a   Poché, Ross A ^a   Saik, Jennifer E ^b,d   Ali, Saniya ^b,c   Wang, Shang ^a   Yosef, Nejla ^a   Calderon, Gisele A ^a,b   Scott, Larry ^a   Vadakkan, Tegy J ^a   Larina, Irina V ^a   West, Jennifer L ^b,c   Dickinson, Mary E ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Rice University   (United States)

^c Duke University   (United States)

^d W L GORE AND ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; COLONY STIMULATING FACTOR 1; FIBROBLAST GROWTH FACTOR 2; MACROGOL; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ANGIOGENIC FACTOR; BECAPLERMIN; HYDROGEL; PLATELET DERIVED GROWTH FACTOR B; VASCULOTROPIN A;

ANASTOMOSIS; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DENSITY; CELL MIGRATION; CELL SURVIVAL; CHEMICAL REACTION KINETICS; CHEMOTAXIS; COCULTURE; CONTROLLED STUDY; CORNEA; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PERICYTE; PHAGOCYTE; POLYMERASE CHAIN REACTION; PROTEIN SECRETION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SIGNAL TRANSDUCTION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SYNTHESIS; TISSUE ENGINEERING; TISSUE PERFUSION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ANIMAL; CELL MOTION; DRUG EFFECTS; PHYSIOLOGY; PROCEDURES; TISSUE SCAFFOLD; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CORNEA; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGELS; MACROPHAGES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-SIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84938841857     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131643     Document Type: Article

References (78)

1. Temenoff JS, Mikos AG (2000) Review: tissue engineering for regeneration of articular cartilage. Biomaterials 21: 431-440. PMID: 10674807
2. Fagerholm P, Lagali NS, Merrett K, Jackson WB, Munger R, et al. (2010) A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study. Sci Transl Med 2: 46ra61. doi: 10.1126/scitranslmed.3001022 PMID: 20739681
3. Bottcher-Haberzeth S, Biedermann T, Reichmann E (2010) Tissue engineering of skin. Burns 36: 450-460. doi: 10.1016/j.burns.2009.08.016 PMID: 20022702
4. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367: 1241-1246. PMID: 16631879
5. Rouwkema J, Rivron NC, van Blitterswijk CA (2008) Vascularization in tissue engineering. Trends Biotechnol 26: 434-441. doi: 10.1016/j.tibtech.2008.04.009 PMID: 18585808
6. Novosel EC, Kleinhans C, Kluger PJ (2011) Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 63: 300-311. doi: 10.1016/j.addr.2011.03.004 PMID: 21396416
7. Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146: 873-887. doi: 10.1016/j.cell.2011.08.039 PMID: 21925313
8. Chu H, Wang Y (2012) Therapeutic angiogenesis: controlled delivery of angiogenic factors. Ther Deliv 3: 693-714. PMID: 22838066
9. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, et al. (2007) Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28: 1123-1131. PMID: 17113636
10. Zieris A, Prokoph S, Levental KR, Welzel PB, Grimmer M, et al. (2010) FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials 31: 7985-7994. doi: 10.1016/j.biomaterials.2010.07.021 PMID: 20674970
11. Moon JJ, Saik JE, Poche RA, Leslie-Barbick JE, Lee SH, et al. (2010) Biomimetic hydrogels with proangiogenic properties. Biomaterials 31: 3840-3847. doi: 10.1016/j.biomaterials.2010.01.104 PMID: 20185173
12. Sun G, Shen YI, Kusuma S, Fox-Talbot K, Steenbergen CJ, et al. (2011) Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Biomaterials 32: 95-106. doi: 10.1016/j.biomaterials.2010.08.091 PMID: 20870284
13. des Rieux A, Ucakar B, Mupendwa BP, Colau D, Feron O, et al. (2011) 3D systems delivering VEGF to promote angiogenesis for tissue engineering. J Control Release 150: 272-278. doi: 10.1016/j.jconrel.2010.11.028 PMID: 21130820
14. Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A, et al. (2003) Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107: 2677-2683. PMID: 12742981
15. Ripa RS, Wang Y, Jorgensen E, Johnsen HE, Hesse B, et al. (2006) Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur Heart J 27: 1785-1792. PMID: 16825290
16. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, et al. (2003) The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107: 1359-1365. PMID: 12642354
17. Annex BH, Simons M (2005) Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. Cardiovasc Res 65: 649-655. PMID: 15664391
18. Molin D, Post MJ (2007) Therapeutic angiogenesis in the heart: protect and serve. Curr Opin Pharmacol 7: 158-163. PMID: 17284359
19. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, et al. (2000) VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102: 898-901. PMID: 10952959
20. Carmeliet P (2000) VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 6: 1102-1103. PMID: 11017137
21. Formiga FR, Pelacho B, Garbayo E, Abizanda G, Gavira JJ, et al. (2010) Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. J Control Release 147: 30-37. doi: 10.1016/j.jconrel.2010.07.097 PMID: 20643169
22. Borselli C, Ungaro F, Oliviero O, d'Angelo I, Quaglia F, et al. (2010) Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres. J Biomed Mater Res A 92: 94-102. doi: 10.1002/jbm.a.32332 PMID: 19165799
23. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, et al. (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9: 604-613. PMID: 12669032
24. Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19: 1029-1034. PMID: 11689847
25. Kano MR, Morishita Y, Iwata C, Iwasaka S, Watabe T, et al. (2005) VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 118: 3759-3768. PMID: 16105884
26. Chen RR, Silva EA, Yuen WW, Mooney DJ (2007) Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24: 258-264. PMID: 17191092
27. Zhang J, Cao R, Zhang Y, Jia T, Cao Y, et al. (2009) Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J 23: 153-163. doi: 10.1096/fj.08-113860 PMID: 18827023
28. Lu H, Xu X, Zhang M, Cao R, Brakenhielm E, et al. (2007) Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs. Proc Natl Acad Sci U S A 104: 12140-12145. PMID: 17636133
29. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, et al. (2004) Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 94: 664-670. PMID: 14739162
30. Deuel TF, Senior RM, Huang JS, Griffin GL (1982) Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 69: 1046-1049. PMID: 7076844
31. Siegbahn A, Hammacher A, Westermark B, Heldin CH (1990) Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest 85: 916-920. PMID: 2155930
32. Zittermann SI, Issekutz AC (2006) Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 168: 835-846. PMID: 16507899
33. Andres G, Leali D, Mitola S, Coltrini D, Camozzi M, et al. (2009) A pro-inflammatory signature mediates FGF2-induced angiogenesis. J Cell Mol Med 13: 2083-2108. doi: 10.1111/j.1582-4934.2008.00415.x PMID: 18624773
34. Fung E, Helisch A (2012) Macrophages in collateral arteriogenesis. Front Physiol 3: 353. doi: 10.3389/fphys.2012.00353 PMID: 23055975
35. Nucera S, Biziato D, De Palma M (2011) The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int J Dev Biol 55: 495-503. doi: 10.1387/ijdb.103227sn PMID: 21732273
36. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51. doi: 10.1016/j.cell.2010.03.014 PMID: 20371344
37. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy PE (2000) Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 87: 378-384. PMID: 10969035
38. Anghelina M, Krishnan P, Moldovan L, Moldovan NI (2006) Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 168: 529-541. PMID: 16436667
39. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, et al. (2010) Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116: 829-840. doi: 10.1182/blood-2009-12-257832 PMID: 20404134
40. Tammela T, Zarkada G, Nurmi H, Jakobsson L, Heinolainen K, et al. (2011) VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol 13: 1202-1213. doi: 10.1038/ncb2331 PMID: 21909098
41. Poche RA, Saik JE, West JL, Dickinson ME (2010) The mouse cornea as a transplantation site for live imaging of engineered tissue constructs. Cold Spring Harb Protoc 2010: pdb prot5416.
42. Larina IV, Shen W, Kelly OG, Hadjantonakis AK, Baron MH, et al. (2009) A membrane associated mCherry fluorescent reporter line for studying vascular remodeling and cardiac function during murine embryonic development. Anat Rec (Hoboken) 292: 333-341.
43. Poche RA, Larina IV, Scott ML, Saik JE, West JL, et al. (2009) The Flk1-myr::mCherry mouse as a useful reporter to characterize multiple aspects of ocular blood vessel development and disease. Dev Dyn 238: 2318-2326. doi: 10.1002/dvdy.21886 PMID: 19253403
44. Sasmono RT, Oceandy D, Pollard JW, Tong W, Pavli P, et al. (2003) A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101: 1155-1163. PMID: 12393599
45. Mann BK, Gobin AS, Tsai AT, Schmedlen RH, West JL (2001) Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering. Biomaterials 22: 3045-3051. PMID: 11575479
46. Wang Y, Narayanaswamy A, Tsai CL, Roysam B (2011) A broadly applicable 3-D neuron tracing method based on open-curve snake. Neuroinformatics 9: 193-217. doi: 10.1007/s12021-011-9110-5 PMID: 21399937
47. Gould DJ, Vadakkan TJ, Poche RA, Dickinson ME (2011) Multifractal and lacunarity analysis of microvascular morphology and remodeling. Microcirculation 18: 136-151. doi: 10.1111/j.1549-8719.2010.00075.x PMID: 21166933
48. Wang S, Lopez AL 3rd, Morikawa Y, Tao G, Li J, et al. (2014) Noncontact quantitative biomechanical characterization of cardiac muscle using shear wave imaging optical coherence tomography. Biomed Opt Express 5: 1980-1992. doi: 10.1364/BOE.5.001980 PMID: 25071943
49. Sudheendran N, Syed SH, Dickinson ME, Larina IV, Larin KV (2011) Speckle variance OCT imaging of the vasculature in live mammalian embryos. Laser Physics Letters 8: 247-252.
50. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. PMID: 11328886
51. Marim FM, Silveira TN, Lima DS Jr., Zamboni DS (2010) A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PLoS One 5: e15263. doi: 10.1371/journal.pone.0015263 PMID: 21179419
52. Koh W, Stratman AN, Sacharidou A, Davis GE (2008) In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis. Methods Enzymol 443: 83-101. doi: 10.1016/S0076-6879(08)02005-3 PMID: 18772012
53. Mariampillai A, Standish BA, Moriyama EH, Khurana M, Munce NR, et al. (2008) Speckle variance detection of microvasculature using swept-source optical coherence tomography. Opt Lett 33: 1530-1532. PMID: 18594688
54. Wang RK (2010) Optical Microangiography: A Label Free 3D Imaging Technology to Visualize and Quantify Blood Circulations within Tissue Beds in vivo. IEEE J Sel Top Quantum Electron 16: 545-554. PMID: 20657761
55. Mahmud MS, Cadotte DW, Vuong B, Sun C, Luk TW, et al. (2013) Review of speckle and phase variance optical coherence tomography to visualize microvascular networks. J Biomed Opt 18: 50901. doi: 10.1117/1.JBO.18.5.050901 PMID: 23616094
56. Zhu X, Bergles DE, Nishiyama A (2008) NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 135: 145-157. PMID: 18045844
57. Fleming TJ, Fleming ML, Malek TR (1993) Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 151: 2399-2408. PMID: 8360469
58. Austyn JM, Gordon S (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11: 805-815. PMID: 7308288
59. Jones GE (2000) Cellular signaling in macrophage migration and chemotaxis. J Leukoc Biol 68: 593-602. PMID: 11073096
60. Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14: 628-638. PMID: 15519852
61. Yu PJ, Ferrari G, Galloway AC, Mignatti P, Pintucci G (2007) Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J Cell Biochem 100: 1100-1108. PMID: 17131363
62. Detillieux KA, Sheikh F, Kardami E, Cattini PA (2003) Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 57: 8-19. PMID: 12504809
63. Woodbury ME, Ikezu T (2014) Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. J Neuroimmune Pharmacol 9: 92-101. doi: 10.1007/s11481-013-9501-5 PMID: 24057103
64. Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22: 1276-1312. doi: 10.1101/gad.1653708 PMID: 18483217
65. Alvarez RH, Kantarjian HM, Cortes JE (2006) Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 81: 1241-1257. PMID: 16970222
66. Hoch RV, Soriano P (2003) Roles of PDGF in animal development. Development 130: 4769-4784. PMID: 12952899
67. Stockmann C, Kerdiles Y, Nomaksteinsky M, Weidemann A, Takeda N, et al. (2010) Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis. Proc Natl Acad Sci U S A 107: 4329-4334. doi: 10.1073/pnas.0912766107 PMID: 20142499
68. Stockmann C, Doedens A, Weidemann A, Zhang N, Takeda N, et al. (2008) Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456: 814-818. doi: 10.1038/nature07445 PMID: 18997773
69. Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496: 445-455. doi: 10.1038/nature12034 PMID: 23619691
70. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11: 750-761. doi: 10.1038/nri3088 PMID: 22025054
71. Gautier EL, Shay T, Miller J, Greter M, Jakubzick C, et al. (2012) Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 13: 1118-1128. doi: 10.1038/ni.2419 PMID: 23023392
72. Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6: 13. doi: 10.12703/P6-13 PMID: 24669294
73. Stefater JA 3rd, Lewkowich I, Rao S, Mariggi G, Carpenter AC, et al. (2011) Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 474: 511-515. doi: 10.1038/nature10085 PMID: 21623369
74. Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, et al. (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443: 993-997. PMID: 17051153
75. Boehler RM, Graham JG, Shea LD (2011) Tissue engineering tools for modulation of the immune response. Biotechniques 51: 239-240, 242, 244 passim. doi: 10.2144/000113754 PMID: 21988690
76. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, et al. (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437: 417-421. PMID: 16163358
77. Lang RA, Bishop JM (1993) Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74: 453-462. PMID: 8348612
78. Poche RA, Hsu CW, McElwee ML, Burns AR, Dickinson ME (2015) Macrophages engulf endothelial cell membrane particles preceding pupillary membrane capillary regression. Dev Biol.